Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T
- PMID: 23751135
- DOI: 10.1016/j.eururo.2013.05.045
Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T
Abstract
Background: A challenge in the diagnosis of prostate cancer (PCa) is the accurate assessment of aggressiveness.
Objective: To validate the performance of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) of the prostate at 3 tesla (T) for the assessment of PCa aggressiveness, with prostatectomy specimens as the reference standard.
Design, settings, and participants: A total of 45 patients with PCa scheduled for prostatectomy were included. This study was approved by the institutional review board; the need for informed consent was waived.
Outcome measurements and statistical analysis: Subjects underwent a clinical MRI protocol including DCE-MRI. Blinded to DCE-images, PCa was indicated on T2-weighted images based on histopathology results from prostatectomy specimens with the use of anatomical landmarks for the precise localization of the tumor. PCa was classified as low-, intermediate-, or high-grade, according to Gleason score. DCE-images were used as an overlay on T2-weighted images; mean and quartile values from semi-quantitative and pharmacokinetic model parameters were extracted per tumor region. Statistical analysis included Spearman's ρ, the Kruskal-Wallis test, and a receiver operating characteristics (ROC) analysis.
Results and limitations: Significant differences were seen for the mean and 75th percentile (p75) values of wash-in (p = 0.024 and p = 0.017, respectively), mean wash-out (p = 0.044), and p75 of transfer constant (K(trans)) (p = 0.035), all between low-grade and high-grade PCa in the peripheral zone. ROC analysis revealed the best discriminating performance between low-grade versus intermediate-grade plus high-grade PCa in the peripheral zone for p75 of wash-in, K(trans), and rate constant (Kep) (area under the curve: 0.72). Due to a limited number of tumors in the transition zone, a definitive conclusion for this region of the prostate could not be drawn.
Conclusions: Quantitative parameters (K(trans) and Kep) and semi-quantitative parameters (wash-in and wash-out) derived from DCE-MRI at 3 T have the potential to assess the aggressiveness of PCa in the peripheral zone. P75 of wash-in, K(trans), and Kep offer the best possibility to discriminate low-grade from intermediate-grade plus high-grade PCa.
Keywords: Dynamic contrast-enhanced MRI; Pharmacokinetic modeling; Prostate cancer; Prostate cancer aggressiveness; Validation study.
Copyright © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Prostate cancer: aggressiveness--MRI can tell.Nat Rev Urol. 2013 Aug;10(8):433. doi: 10.1038/nrurol.2013.140. Epub 2013 Jun 18. Nat Rev Urol. 2013. PMID: 23774958 No abstract available.
Similar articles
-
Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.Abdom Radiol (NY). 2020 Jul;45(7):2225-2234. doi: 10.1007/s00261-019-02234-6. Abdom Radiol (NY). 2020. PMID: 31549211 Free PMC article.
-
A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.Eur Radiol. 2018 May;28(5):1949-1960. doi: 10.1007/s00330-017-5192-2. Epub 2017 Dec 13. Eur Radiol. 2018. PMID: 29238867
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.J Magn Reson Imaging. 2017 Sep;46(3):837-849. doi: 10.1002/jmri.25631. Epub 2017 Jan 16. J Magn Reson Imaging. 2017. PMID: 28092414
-
Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.Invest Radiol. 2015 Aug;50(8):490-7. doi: 10.1097/RLI.0000000000000157. Invest Radiol. 2015. PMID: 25867656
Cited by
-
Quantitative Analysis of Prostate MRI: Correlation between Contrast-Enhanced Magnetic Resonance Fingerprinting and Dynamic Contrast-Enhanced MRI Parameters.Curr Oncol. 2023 Dec 4;30(12):10299-10310. doi: 10.3390/curroncol30120750. Curr Oncol. 2023. PMID: 38132384 Free PMC article.
-
Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate-Unnecessary or Underutilised? A Narrative Review.Diagnostics (Basel). 2023 Nov 20;13(22):3488. doi: 10.3390/diagnostics13223488. Diagnostics (Basel). 2023. PMID: 37998624 Free PMC article. Review.
-
Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Parameters Could Predict International Society of Urological Pathology Risk Groups of Prostate Cancers on Radical Prostatectomy.Life (Basel). 2023 Sep 21;13(9):1944. doi: 10.3390/life13091944. Life (Basel). 2023. PMID: 37763347 Free PMC article.
-
Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI, (68)Ga-PSMA PET/CT, PSA, and PSA-density comparison study.Diagn Interv Radiol. 2023 Sep 5;29(5):647-655. doi: 10.4274/dir.2023.232186. Epub 2023 Jul 3. Diagn Interv Radiol. 2023. PMID: 37395389 Free PMC article.
-
Radiogenomics Reveals Correlation between Quantitative Texture Radiomic Features of Biparametric MRI and Hypoxia-Related Gene Expression in Men with Localised Prostate Cancer.J Clin Med. 2023 Mar 30;12(7):2605. doi: 10.3390/jcm12072605. J Clin Med. 2023. PMID: 37048688 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials